Genetic and pharmacological IL11 blockade reduces inflammaging, improving healthspan, lifespan, and longevity in male and female mice, highlighting IL11 as a new inflammatory aging clock and a potential molecular target in inflammaging‐associated human degenerative diseases. This evidence concerns the gene CLOCK and neurodegenerative disease.